How Does Medical Device Reimbursement Work? The End-to-End Guide for MedTech Founders

2026-08-20 · Caduvo Team

A plain-English guide to how medical device reimbursement works: CPT/HCPCS coding, coverage, payment, and why founders need a strategy before design freeze.

Most device founders focus on FDA clearance. They assume that once they have it, hospitals will pay. That assumption has killed more startups than any regulatory misstep. Here is how medical device reimbursement actually works — and why you need a plan before you freeze your design.

The coding-coverage-payment framework

Reimbursement isn’t one thing. It’s three distinct legs, and your device has to stand on all of them.

• Coding — A numeric or alphanumeric label that describes what was done or what was used. Without a code, a provider can’t submit a claim.
• Coverage — A payer’s decision about whether they will pay for a service or item that’s billed under a specific code. Coverage is often conditional: tied to diagnoses, settings, or clinical criteria.
• Payment — The actual dollar amount, set via a fee schedule, a DRG weight, or a negotiated rate.

A device can have a code and still get denied payment if coverage is missing. It can be covered but underpaid if the payment mechanism doesn’t reflect its cost. You need all three.

CPT and HCPCS: Your device needs a ticket to get paid

Two coding systems matter most. CPT and HCPCS codes are different tickets, and choosing the wrong lane can delay revenue by years.

• CPT (Current Procedural Terminology) codes describe procedures and services performed by physicians or other clinicians. Maintained by the AMA. If your device enables a new procedure, you may need a new Category I CPT code — a multi-year process that requires published clinical evidence.
• HCPCS Level II codes identify products, supplies, drugs, and durable medical equipment. Administered by CMS. Often faster to obtain, but the bar is that no existing code adequately describes the item.

Many devices end up piggybacking on an existing procedural CPT code while seeking a HCPCS code for the device itself. For example, a novel implant used during fusion surgery might bill the fusion CPT code and separately bill the implant under an HCPCS code if it doesn’t fit the standard surgical supply bundle. If you don’t know what is an HCPCS code and whether your device qualifies for one, you are guessing about your revenue model.

Medicare vs commercial payers

Medicare sets the floor. Private insurers often follow — but not always, and not quickly. That makes Medicare medical device reimbursement the foundation of any strategy.

• Medicare coverage comes in two flavors: national coverage determinations (NCDs) and local coverage determinations (LCDs). An NCD applies nationwide; an LCD applies only within a Medicare Administrative Contractor’s jurisdiction. Most devices start by targeting favorable LCDs while gathering evidence for a future NCD.
• Payment varies by site. In the hospital outpatient setting, devices may be packaged into an APC payment. In the inpatient setting, they often sit inside a DRG. DME has its own fee schedule that pays a set rate per item per month.

Commercial payers layer on their own medical policies, prior authorization requirements, and fee schedules. Getting a positive coverage policy from a large Blues plan can be as valuable as an NCD — but the evidence demands are different. Plan sponsors ask, “Does this device reduce total cost of care or improve outcomes enough to justify the premium?” Document that answer early.

Why reimbursement strategy must start before design freeze

You cannot bolt on a medical device reimbursement strategy after your device is built. The features you lock in during development determine the codes you’ll chase, the evidence you’ll need, and the payment pathway you’ll fit into.

Consider two common dead-ends:

1. A device adds a $1,200 disposable to a procedure currently paid under an APC that bundles supplies. Unless you can get a transitional pass‑through payment or a new APC, hospitals lose money every time they use it. Adoption stalls.
2. A monitoring device collects continuous data, but existing remote physiologic monitoring CPT codes require 16 or more days of data. If your product only captures 10 days, you can’t bill those codes. By the time you learn this, redesigning the product to meet the code requirement would take 12 months and a new 510(k).

Both scenarios are avoidable. Mapping reimbursement constraints during concept development lets you align design choices with existing codes or evidence requirements for a new one. If your device qualifies for Breakthrough Device Designation, the Transitional Coverage for Emerging Technologies (TCET) pathway can provide a Medicare coverage bridge — but only if you plan for it early and structure your clinical evidence accordingly.

A founder’s checklist for early reimbursement planning

Here’s what to do before you lock your device specs:

1. Identify the clinical encounter where your device will be used. Which provider performs the service? Outpatient or inpatient? This dictates whether you’ll deal with CPT, HCPCS, DRGs, or a fee schedule.
2. Search the Medicare coverage database for existing NCDs and LCDs that relate to your device’s intended use. Note the exact language payers use to describe covered indications.
3. Map comparable devices to their current coding. If the closest competitor uses an unlisted CPT code, assume revenue will be unpredictable until you get a specific code.
4. Model the hospital payment for the episode. If your device increases cost above the existing payment, you need a plan — new technology add-on payment, a new HCPCS, or a cost-offset argument solid enough for value analysis committees.
5. Talk to medical directors at a few target hospital systems. Ask what evidence they would need to bring the device through a value analysis committee. Write that list down; get it in writing if you can.
6. Decide if you will pursue a new code. Start the CPT application or HCPCS code request early — the process can take 18 months or more, and you’ll need published data.

Tools that auto‑analyze coding and coverage landscapes can flag gaps before you commit to a design, helping you see exactly where the payment floor sits relative to your cost. That data lets you build a medical device reimbursement strategy that isn’t aspirational — it’s actionable.